Sign in

CIK 0001937653

  • Non-accelerated filer
  • Smaller reporting company

Zymeworks Inc.

Sign in to watch
Ticker
ZYME
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
883099146
Phone
+1 302-274-8744
Business address
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
Former names
Zymeworks Delaware Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,393,518
in 2 filings

Net −$1,393,518. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-13 Moore Paul Andrew Chief Scientific Officer Option exercise +25,000 $5.82 $146K 73,497
2026-11-13 Moore Paul Andrew Chief Scientific Officer Sale −7,367 $26.14 $193K 66,130
2026-11-13 Moore Paul Andrew Chief Scientific Officer Sale −7,374 $26.09 $192K 58,756
2026-11-13 Moore Paul Andrew Chief Scientific Officer Sale −25,000 $26.04 $651K 33,756
2026-11-13 Moore Paul Andrew Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −25,000 175,000
2026-10-09 Schayowitz Adam EVP, Head of R&D Option exercise +37,037 37,037
2026-10-09 Schayowitz Adam EVP, Head of R&D Sale −13,832 $25.85 $358K 23,205
2026-10-09 Schayowitz Adam EVP, Head of R&D Option exercise · Restricted Stock Unit −37,037 74,074
2026-07-06 Hollywood Mark EVP & Chief Operating Officer Grant or award +939 $22.22 $21K 133,852
2026-05-13 Schneider Paul R EVP, General Counsel Grant or award · Stock Option (Right to Buy) +178,000 178,000
2026-05-13 Schneider Paul R EVP, General Counsel Grant or award · Restricted Stock Unit +119,000 119,000
2026-04-09 Schayowitz Adam See Remarks Grant or award · Stock Option (Right to Buy) +70,000 70,000
2026-04-09 Schayowitz Adam See Remarks Grant or award · Restricted Stock Unit +47,000 47,000
2026-04-09 Schayowitz Adam See Remarks Grant or award · Performance Stock Unit +76,000 76,000
2026-04-09 Platshon Scott EVP, Chief Business Officer Grant or award · Stock Option (Right to Buy) +70,000 70,000
2026-04-09 Platshon Scott EVP, Chief Business Officer Grant or award · Restricted Stock Unit +47,000 47,000
2026-04-09 Platshon Scott EVP, Chief Business Officer Grant or award · Performance Stock Unit +76,000 76,000
2026-04-06 Stafford Kristin EVP, Chief Financial Officer Grant or award · Stock Option (Right to Buy) +178,000 178,000
2026-04-06 Stafford Kristin EVP, Chief Financial Officer Grant or award · Restricted Stock Unit +119,000 119,000
2026-04-06 Stafford Kristin EVP, Chief Financial Officer Grant or award · Restricted Stock Unit +50,000 50,000

Page 1 of 12 · 229 trades